Stephen Langabeer 2022. Molecular screening for an underlying myeloproliferative neoplasm in rheumatology patients. Archives of Rheumatology. 37, 3 (Sep. 2022), 475–476. DOI:https://doi.org/10.46497/ArchRheumatol.2022.9274.